Allergy Treatment Market: Developments in Food Allergy Treatments Contribute Significantly to Market Growth

According to The Insight Partners market research study titled “Allergy Treatment Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Allergy Type and Treatment,” the market is expected to reach US$ 35,812.33 million by 2028 from US$ 21,160.92 million in 2020; it is estimated to grow at a CAGR of 6.9% from 2021 to 2028. The report highlights the trends prevailing in the global allergy treatment market, along with market drivers and deterrents.
Allergy Treatment Market: Competition Landscape and Key Developments
Johnson and Johnson Services, Inc.; Sanofi; AbbVie Inc. (Allergan plc); Pfizer Inc.; LETIPharma; ALK-Abelló A/S; Allergy Therapeutics; Stallergenes Greer; GlaxoSmithKline plc; and Dermapharm Holding. Market players are introducing new and innovative products and services to sustain their position in the allergy treatment market.
For instance, in September 2019, Allergy Therapeutics, a biotechnology company, announced investments in exploring the applications of virus-like particle (VLP) technology in the field of allergy immunotherapy. It has entered into an exclusive license agreement with Saiba and DeepVax to use their patented VLP technology platform in the development and commercialization of vaccines targeting solid cancer tumors, atopic dermatitis, asthma, and psoriasis.
Get Exclusive Sample Pages of Allergy Treatment Market - Global Analysis and Strategic Insights at: https://www.theinsightpartners.com/sample/TIPRE00004584/ 
The COVID-19 pandemic is estimated to have a positive impact on the allergy treatment market. Majority of the pharmaceutical companies across the world are engaged in the development of vaccines against this disease. Moreover, allergy and asthma exacerbations are frequently triggered by viral infections, including coronaviruses. Thus, telehealth can be central in delivering allergy/immunology services within a risk-stratified context of the SARS-CoV-2 pandemic which is anticipated to have a positive impact on the other segments of the market in the coming months. However, disruptions in the supply chain caused due to the halt in global operations are hindering the market growth.
Allergy is a common medical condition among a large share of global population. It is one of the chronic health conditions that may result in severe consequences. Food allergies are ubiquitous in North America and Europe. The majority of people are allergic to garlic, wheat, peanuts, milk, fish, etc. According to estimations of the Center for Biologics Evaluation and Research of the Food and Drug Administration (FDA), ~1 million children in the US are allergic to peanuts, and one in five of these children is likely to surmount the respective allergy condition. In those who don’t outgrowth this allergy, the small intake of peanuts is unpredictable and harmful, which may result in severe reactions. Therefore, it becomes essential to develop treatment options for allergies to such common foodstuff.
Developments in the pharmaceuticals industry have enabled companies to offer treatment for peanut allergy reactions. In February 2020, the US FDA approved Palforzia, peanut (Arachis hypogaea) allergen powder-dnfp, as a treatment for peanut allergy, which is intended to alleviate allergic reactions such as anaphylaxis resulting from accidental peanut intake. The product is developed for children from age group of 4–17. Palforzia was developed by Aimmune Therapeutics, Inc., a Nestle Health Science Company. It is administered in three dosages such as initial dose escalation, up-dosing, and maintenance. Palforzia is packaged in pull-apart color-coded capsules for dose escalation and up-dosing, and in sachets for the maintenance stage. While administering, it is mixed with a semi-solid food such as curd and pudding. It has been made available in the US, Canada, and Europe. Such developments in the food allergy treatment options and their effectiveness are the factors boosting the allergy treatment market growth.
Allergy treatment Market: Segmental Overview
Based on allergy type, the global allergy treatment market is segmented into eye allergy, rhinitis, asthma, skin allergy, food allergies, and other allergies. In 2020, the rhinitis segment held the largest share of the market; it is also expected to be a leading shareholder in the market by 2028. The market growth is mainly attributed to the growing prevalence of rhinitis worldwide, which is likely to continue in the coming years due to constant climatic and environmental changes, thereby boosting the demand for decongestants, antihistamines, and topical/oral steroids worldwide.
Immunotherapy is offered in two different types—allergy shots and sublingual immunotherapy (SLIT). Allergy shots are the extracts of allergens that are administered with increasing dosage; they are effective for allergies caused by asthma, pets, dust, pollen, bees, and other stinging insects. Generally, SLIT tablets are administered daily by keeping them under the tongue; this type is an effective treatment option for nasal allergies and asthma. The administration of repetitive dosage of allergen makes patients less sensitive to that allergen, thus providing relief from allergic symptoms. Immunotherapy has shown positive and long-term benefits in allergic patients. Moreover, it is suitable for self-administration and medicine usage in homecare settings. Therefore, immunotherapy has emerged as a safe and effective alternative subcutaneous route for both chronic and recurrent allergies.
Place an Order Copy of Allergy Treatment Market Report at: https://www.theinsightpartners.com/buy/TIPRE00004584/ 
Browse Related Report Here:
Allergy Immunotherapy Market Forecast to 2028 - Covid-19 Impact and Global Analysis - by Treatment (Subcutaneous Immunotherapy (SCIT), Sublingual Immunotherapy (SLIT)); Allergy Type (Asthma, Food Allergy, Allergic Rhinitis, Venom Allergy, Others); Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies) and Geography
https://www.theinsightpartners.com/reports/allergy-immunotherapy-market 
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876

Back to news